Cary L. Majors - 31 May 2023 Form 4 Insider Report for STERIS plc (STE)

Role
SVP and President, Healthcare
Signature
/s/ Ronald E. Snyder, Authorized Representative under Power of Attorney
Issuer symbol
STE
Transactions as of
31 May 2023
Net transactions value
-$129,781
Form type
4
Filing time
02 Jun 2023, 16:30:45 UTC
Previous filing
07 Mar 2023
Next filing
15 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STE Ordinary Shares Tax liability $129,781 -649 -5.7% $199.97 10,696 31 May 2023 Direct F1, F2
transaction STE Ordinary Shares Award $0 +2,697 +25% $0.000000 13,393 31 May 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STE Employee Stock Option (right to buy) Award $0 +15,148 $0.000000 15,148 31 May 2023 Ordinary Shares 15,148 $219.97 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 649 shares were withheld from the 2,224 restricted shares that vested on May 31, 2023. These 649 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,224 ordinary shares were awarded to Mr. Majors on May 31, 2019. These vested shares were valued at the NYSE closing market price on May 31, 2023.
F2 As of May 31, 2023, 9,860 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,367 on June 3, 2024; 1,964 on June 2, 2025; 692 on October 1, 2025; 2,697 on June 1, 2026 and 2,140 on June 2, 2026.
F3 This option becomes exercisable as follows: 3,787 on May 31, 2024; 3,787 on June 2, 2025; 3,787 on June 1, 2026 and 3,787 on June 1, 2027.